T Philip

913 total citations
46 papers, 692 citations indexed

About

T Philip is a scholar working on Neurology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, T Philip has authored 46 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 9 papers in Pathology and Forensic Medicine and 9 papers in Oncology. Recurrent topics in T Philip's work include Neuroblastoma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). T Philip is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Lymphoma Diagnosis and Treatment (9 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). T Philip collaborates with scholars based in France, United States and Italy. T Philip's co-authors include Gilbert Lenoir, Pierre Biron, Jean‐Yves Blay, Jacques Banchereau, Nicolas Burdin, F Rousset, M Favrot, Didier Frappaz, Christine Lasset and I Philip and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

T Philip

44 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Philip France 14 265 248 206 167 165 46 692
VM Santana United States 9 310 1.2× 176 0.7× 185 0.9× 119 0.7× 101 0.6× 11 674
J.P. Vannier France 10 185 0.7× 190 0.8× 203 1.0× 264 1.6× 69 0.4× 26 659
MY Mapara Germany 10 443 1.7× 177 0.7× 150 0.7× 444 2.7× 161 1.0× 11 795
WM Roberts United States 12 285 1.1× 138 0.6× 367 1.8× 141 0.8× 263 1.6× 19 1.0k
Yasumasa Monobe Japan 13 199 0.8× 222 0.9× 188 0.9× 88 0.5× 81 0.5× 75 856
O Gentilhomme France 18 328 1.2× 193 0.8× 247 1.2× 310 1.9× 161 1.0× 39 1.0k
Rosita L. ten Berge Netherlands 12 281 1.1× 89 0.4× 180 0.9× 434 2.6× 235 1.4× 18 717
R. Handgretinger Germany 15 222 0.8× 286 1.2× 228 1.1× 43 0.3× 226 1.4× 33 718
Thérèse Rousset France 9 346 1.3× 87 0.4× 168 0.8× 445 2.7× 171 1.0× 12 714
PA Jr Bunn United States 7 151 0.6× 152 0.6× 102 0.5× 139 0.8× 73 0.4× 11 467

Countries citing papers authored by T Philip

Since Specialization
Citations

This map shows the geographic impact of T Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Philip more than expected).

Fields of papers citing papers by T Philip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Philip. The network helps show where T Philip may publish in the future.

Co-authorship network of co-authors of T Philip

This figure shows the co-authorship network connecting the top 25 collaborators of T Philip. A scholar is included among the top collaborators of T Philip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Philip. T Philip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chawla, Sant P., Brian A. Van Tine, Seth M. Pollack, et al.. (2017). A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival. Annals of Oncology. 28. v523–v523. 12 indexed citations
2.
Perrier, Lionel, et al.. (2002). [Necessary harmonization of health cost assessment. Autologous peripheral blood progenitor cell transplantation in France].. PubMed. 50(4). 393–403. 1 indexed citations
3.
Combaret, Valérie, Christine Lasset, R Bouvier, et al.. (1997). Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression. British Journal of Cancer. 75(8). 1151–1155. 16 indexed citations
4.
Combaret, Valérie, Christine Lasset, Didier Frappaz, et al.. (1996). Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.. Journal of Clinical Oncology. 14(1). 25–34. 76 indexed citations
5.
Estève, Jacques, Louise Parker, Pascal Roy, et al.. (1995). Is neuroblastoma screening evaluation needed and feasible?. British Journal of Cancer. 71(6). 1125–1131. 31 indexed citations
6.
Combaret, Valérie, Christine Lasset, R Bouvier, et al.. (1995). [CD44 expression: a new prognostic factor in neuroblastoma].. PubMed. 82(2). 131–6. 2 indexed citations
7.
Philip, T & Didier Frappaz. (1993). Avant-propos : Cancers de l'enfant. La Revue du praticien. 43(17). 2173–2175. 4 indexed citations
8.
Philip, T, Olivier Hartmann, Ross Pinkerton, et al.. (1993). Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique. Blood. 81(8). 2003–2006. 1 indexed citations
9.
Lasset, Christine, Olivier Hartmann, Guglielmo Dini, et al.. (1992). The Lyon and the Ebmt Data On Megatherapy (Mgt) in Neuroblastoma Followed by Bone-Marrow Rescue. Bone Marrow Transplantation. 10(2). 14–14. 2 indexed citations
10.
Maraninchi, D, Patrice Viens, Michel Legros, et al.. (1990). Hautes doses d'alkylants et autogreffe de moelle dans les cancers de l'ovaire à mauvais pronostic : une analyse rétrospective de 40 patientes traitées en France. Bulletin du Cancer. 77(2). 149–157.
11.
Dini, Giorgio, T Philip, Olivier Hartmann, et al.. (1989). Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group.. PubMed. 4 Suppl 4. 42–6. 14 indexed citations
12.
Combaret, Valérie, M Favrot, Philippe Thiesse, et al.. (1989). Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols. European Journal of Cancer and Clinical Oncology. 25(11). 1607–1612. 22 indexed citations
13.
Bellon, G., Éric Bouffet, Pierre Biron, et al.. (1989). Lavage broncho-alvéolaire par fibroscopie chez l'enfant immuno-déprimé. 44(1). 45–51. 2 indexed citations
14.
Philip, T, Olivier Hartmann, Charles S. August, et al.. (1988). Stage IV neuroblastoma alive progression free 17 months post-BMT are not cured. Bone Marrow Transplantation. 3. 1 indexed citations
15.
Hartmann, Olivier, CR Pinkerton, T Philip, J M Zucker, & F. Breatnach. (1988). Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma.. Journal of Clinical Oncology. 6(1). 44–50. 52 indexed citations
16.
Kremens, Bernhard, et al.. (1988). S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft.. PubMed. 3(3). 221–7. 6 indexed citations
17.
Favrot, M, et al.. (1987). Experimental evaluation of an immunomagnetic bone marrow purging procedure using the Burkitt lymphoma model.. PubMed. 2(1). 59–66. 7 indexed citations
18.
Philip, I, M Favrot, & T Philip. (1987). Use of a liquid cell culture assay to quantify the elimination of Burkitt lymphoma cells from the bone marrow. Journal of Immunological Methods. 97(1). 11–17. 6 indexed citations
19.
Favrot, M, et al.. (1984). Distinct Reactivity of Burkitt's Lymphoma Cell Lines With Eight Monoclonal Antibodies Correlated With the Ethnic Origin. JNCI Journal of the National Cancer Institute. 73(4). 841–7. 31 indexed citations
20.
Hervé, P, Emmanuel Plouvier, Bernard Lamy, et al.. (1981). [Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)].. PubMed. 10(24). 2001–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026